ID

Ian Dixon

Entropy Neurodynamics Limited | Chief Executive Officer
Dr Dixon brings to the Board entrepreneurial and technical experience in founding, building, and running listed and unlisted technology-based companies. In 2014, he co-founded Cardio Therapeutics Pty Ltd and managed the PCSK9 cardiovascular discovery program until the company was acquired by Nyrada Inc in advance of the IPO of Nyrada in 2019. He is member of Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
ENP
ENP
Entropy Neurodynamics Limited
  • Chief Executive Officer
13yrs, 2mthMay 2013
NYR
NYR
Nyrada Inc
  • Founder
  • Non-Executive Director
5yrs, 10mthSep 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NYR
NYR
Nyrada Inc
20/02/26N/A9,780,6991,800,000N/A
ENP
ENP
Entropy Neurodynamics Limited
01/05/24N/A11,303,451N/AN/A
TYP
TYP
01/05/24N/A11,303,451N/AN/A
EX1
EX1
19/04/24N/A11,303,451N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NYR
NYR
Nyrada Inc
20/02/26
Issued
1,200,000$0.580$696,000Issue of options
NYR
NYR
Nyrada Inc
18/12/25
Sell
600,000$0.646$387,600Off-market trade
NYR
NYR
Nyrada Inc
12/06/24
Issued
266,666$0.075$19,999Placement
EX1
EX1
01/09/21
Buy
83,333$0.535$44,583Conversion of securities
EX1
EX1
01/09/21
Exercise
83,333$0.535$44,583Conversion of securities